225 related articles for article (PubMed ID: 29191656)
1. Overexpression of microRNA-26a protects against deficient β-cell function via targeting phosphatase with tensin homology in mouse models of type 2 diabetes.
Song Y; Jin D; Jiang X; Lv C; Zhu H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1312-1316. PubMed ID: 29191656
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function.
Xu H; Du X; Xu J; Zhang Y; Tian Y; Liu G; Wang X; Ma M; Du W; Liu Y; Dai L; Huang W; Tong N; Wei Y; Fu X
PLoS Biol; 2020 Feb; 18(2):e3000603. PubMed ID: 32092075
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26a overexpression protects RGC-5 cells against H2O2-induced apoptosis.
Kang Y; Jia P; Zhao H; Hu C; Yang X
Biochem Biophys Res Commun; 2015 May; 460(2):164-9. PubMed ID: 25757910
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of miR-26a promotes neurite outgrowth and ameliorates apoptosis by inhibiting PTEN in bupivacaine injured mouse dorsal root ganglia.
Cui C; Xu G; Qiu J; Fan X
Cell Biol Int; 2015 Aug; 39(8):933-42. PubMed ID: 25808510
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.
Wang L; Liu Y; Yan Lu S; Nguyen KT; Schroer SA; Suzuki A; Mak TW; Gaisano H; Woo M
Diabetes; 2010 Dec; 59(12):3117-26. PubMed ID: 20852026
[TBL] [Abstract][Full Text] [Related]
6. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
7. MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN.
Wang L; Zhang N; Pan HP; Wang Z; Cao ZY
Cell Physiol Biochem; 2015; 36(6):2357-65. PubMed ID: 26279439
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-conditioned medium alleviates high fat-induced hyperglucagonemia via miR-181a-5p and its target PTEN/AKT signaling.
Song J; He Q; Guo X; Wang L; Wang J; Cui C; Hu H; Yang M; Cui Y; Zang N; Yan F; Liu F; Sun Y; Liang K; Qin J; Zhao R; Wang C; Sun Z; Hou X; Li W; Chen L
Mol Cell Endocrinol; 2021 Nov; 537():111445. PubMed ID: 34464683
[TBL] [Abstract][Full Text] [Related]
9. MiR-26a promotes neurite outgrowth by repressing PTEN expression.
Li B; Sun H
Mol Med Rep; 2013 Aug; 8(2):676-80. PubMed ID: 23783805
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 sponges miR-26a to regulate the migration and proliferation of vascular smooth muscle cells.
Tian S; Yuan Y; Li Z; Gao M; Lu Y; Gao H
Gene; 2018 Oct; 673():159-166. PubMed ID: 29908280
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-96 regulates pancreatic β cell function under the pathological condition of diabetes mellitus through targeting Foxo1 and Sox6.
Qi H; Yao L; Liu Q
Biochem Biophys Res Commun; 2019 Nov; 519(2):294-301. PubMed ID: 31506178
[TBL] [Abstract][Full Text] [Related]
13. MiR-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression.
Yu N; Yang Y; Li X; Zhang M; Huang J; Wang X; Long X
Gene; 2016 Dec; 594(1):117-124. PubMed ID: 27613140
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells.
Li J; An G; Zhang M; Ma Q
Biochem Biophys Res Commun; 2016 Sep; 477(4):743-748. PubMed ID: 27363339
[TBL] [Abstract][Full Text] [Related]
15. Abnormal Expression of microRNA-296-3p in Type 2 Diabetes Patients and its Role in Pancreatic β-Cells Function by Targeting Tensin Homolog Deleted on Chromosome Ten.
Cheng M; Guo Y; Zhong W; Chen X; Guo G
Biochem Genet; 2022 Feb; 60(1):39-53. PubMed ID: 34085179
[TBL] [Abstract][Full Text] [Related]
16. Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells.
Li W; Jiang Y; Wu X; Yang F
Cancer Biother Radiopharm; 2019 Sep; 34(7):480-485. PubMed ID: 31135180
[No Abstract] [Full Text] [Related]
17. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K
Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a regulates cerebral ischemia injury through targeting PTEN.
Guo XL; Liang H; Sun Y; Wang CB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7033-7041. PubMed ID: 31486504
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue.
Ling HY; Hu B; Hu XB; Zhong J; Feng SD; Qin L; Liu G; Wen GB; Liao DF
Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):553-9. PubMed ID: 22956257
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.
Sebastiani G; Po A; Miele E; Ventriglia G; Ceccarelli E; Bugliani M; Marselli L; Marchetti P; Gulino A; Ferretti E; Dotta F
Acta Diabetol; 2015 Jun; 52(3):523-30. PubMed ID: 25408296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
